Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dellborg

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Lakartidningen|September 15, 1993
[Oxygen--when, why, how? Treatment of chronic hypoxia and other lung diseases]M Dellborg, L Leksell, B Midgren, et al.
Cardiovascular Drugs and Therapy|April 13, 2001
Long-term mortality after acute myocardial infarction in relation to prescribed dosages of a beta-blocker at hospital dischargeJ Herlitz, M Dellborg, B W Karlson, et al.
European Heart Journal|July 2, 2002
Continuous multilead ST-monitoring identifies patients with unstable coronary artery disease who benefit from extended antithrombotic treatmentT Jernberg, P Abrahamsson, B Lindahl, et al.
American Heart Journal|April 30, 1999
Effect of intravenous metoprolol before hospital admission on chest pain in suspected acute myocardial infarctionM Gardtman, M Dellborg, C Brunnhage, et al.
Clinical Cardiology|June 19, 1998
Occurrence, characteristics, and outcome of patients hospitalized with a diagnosis of acute myocardial infarction who do not fulfill traditional criteriaJ Herlitz, T Karlsson, M Dellborg, et al.
Cardiology|May 7, 1998
One-year mortality after acute myocardial infarction prior to and after the implementation of a widespread use of thrombolysis and aspirin. Experiences from the community of Göteborg, SwedenJ Herlitz, M Hartford, B W Karlson, et al.
Clinical Cardiology|April 5, 2001
The low-molecular-weight heparin dalteparin as adjuvant therapy in acute myocardial infarction: the ASSENT PLUS studyL Wallentin, D M Dellborg, B Lindahl, et al.
Cardiology|January 1, 1995
Diagnostic accuracy of physicians for identifying patients with acute myocardial infarction without an electrocardiogram. Experiences from the TEAHAT TrialJ Herlitz, B W Karlson, T Karlsson, et al.
Cardiology|November 5, 1999
Long-term survival after development of acute myocardial infarction has improved after a more widespread use of thrombolysis and aspirinJ Herlitz, P Abrahamsson, M Dellborg, et al.
Journal of the American College of Cardiology|May 20, 1999
Admission risk assessment by cardiac troponin T in unstable coronary artery disease: additional prognostic information from continuous ST segment monitoring. TRIM study group. Thrombin Inhibition in Myocardial IschemiaB L Nørgaard, K Andersen, M Dellborg, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Lakartidningen|September 15, 1993
[Oxygen--when, why, how? Treatment of chronic hypoxia and other lung diseases]M Dellborg, L Leksell, B Midgren, et al.
Cardiovascular Drugs and Therapy|April 13, 2001
Long-term mortality after acute myocardial infarction in relation to prescribed dosages of a beta-blocker at hospital dischargeJ Herlitz, M Dellborg, B W Karlson, et al.
European Heart Journal|July 2, 2002
Continuous multilead ST-monitoring identifies patients with unstable coronary artery disease who benefit from extended antithrombotic treatmentT Jernberg, P Abrahamsson, B Lindahl, et al.
American Heart Journal|April 30, 1999
Effect of intravenous metoprolol before hospital admission on chest pain in suspected acute myocardial infarctionM Gardtman, M Dellborg, C Brunnhage, et al.
Clinical Cardiology|June 19, 1998
Occurrence, characteristics, and outcome of patients hospitalized with a diagnosis of acute myocardial infarction who do not fulfill traditional criteriaJ Herlitz, T Karlsson, M Dellborg, et al.
Cardiology|May 7, 1998
One-year mortality after acute myocardial infarction prior to and after the implementation of a widespread use of thrombolysis and aspirin. Experiences from the community of Göteborg, SwedenJ Herlitz, M Hartford, B W Karlson, et al.
Clinical Cardiology|April 5, 2001
The low-molecular-weight heparin dalteparin as adjuvant therapy in acute myocardial infarction: the ASSENT PLUS studyL Wallentin, D M Dellborg, B Lindahl, et al.
Cardiology|January 1, 1995
Diagnostic accuracy of physicians for identifying patients with acute myocardial infarction without an electrocardiogram. Experiences from the TEAHAT TrialJ Herlitz, B W Karlson, T Karlsson, et al.
Cardiology|November 5, 1999
Long-term survival after development of acute myocardial infarction has improved after a more widespread use of thrombolysis and aspirinJ Herlitz, P Abrahamsson, M Dellborg, et al.
Journal of the American College of Cardiology|May 20, 1999
Admission risk assessment by cardiac troponin T in unstable coronary artery disease: additional prognostic information from continuous ST segment monitoring. TRIM study group. Thrombin Inhibition in Myocardial IschemiaB L Nørgaard, K Andersen, M Dellborg, et al.
Pageof 10